Association of statins with autoimmune disorders is rarely reported. We report a case of an apparently healthy 76-year-old woman who was on long-term statin therapy presenting with severe rhabdomyolysis, autoimmune hepatitis, and positive lupus antibodies. Patient presented with complaints of worsening fatigue, leg cramps, and progressive weakening of lower extremities over 3 weeks. The patient was on simvastatin daily for several years. Clinical examination on admission included muscle tenderness, lower extremity edema, and ascites. Her laboratory values on admission showed elevated creatine kinase and transaminases. Immunologic workup revealed positive ANA, anti-dsDNA and anti-SSA antibodies. F-actin antibody was also positive at high titer. Magnetic resonance imaging of the lower extremities showed findings consistent with myositis. Patient underwent biopsy of the thigh muscles, which showed inflammatory myositis. Liver biopsy was characteristic of autoimmune hepatitis. Patient responded well to immunosuppressive therapy with azathioprine and prednisone. Although statins are generally considered safe, recent data from long-term follow-up on patients who are on statins for long duration suggest that prolonged exposure to statins may trigger autoimmune reactions. The exact mechanism of statin-induced autoimmune reaction is unclear. Statins, as proapoptotic agents, release nuclear antigen into the circulation and may induce the production of pathogenic autoantibodies. The role of statins in inducing an endoplasmic reticular stress response with associated upregulation of major histocompatibility complex-1 expression and antigen presentation by muscle fibers has also been reported. Systemic immunosuppressive therapy has proven to be effective in many reported cases.
INTRODUCTION
Statins are widely prescribed medications with documented cardiovascular benefits. Statins are known to cause myositis and rarely hepatitis, but their association with autoimmune disorders is rarely reported. We report a case of an apparently healthy woman who was on long-term statin therapy presenting with severe rhabdomyolysis, autoimmune hepatitis, and positive lupus antibodies.
CASE REPORT
Our patient is a 76-year-old woman with history of dyslipidemia and diet-controlled diabetes mellitus. She was admitted to the hospital with complaints of worsening fatigue, leg cramps, and progressive weakening of lower extremities over 3 weeks. She also noticed increasing leg swelling, abdominal distension, and jaundice over the same period. The patient was otherwise asymptomatic, before the onset of her symptoms. The patient was on 80 mg of simvastatin daily for several years. Clinical examination on admission included icterus, severe tenderness of extremity musculature, lower extremity edema, and ascites. Her admission labs showed white blood count of 6.6/mm 3 , hemoglobin 12.1 g%, and platelets 190,000/mm 3 . Creatine kinase was 29,000 IU/dL, and liver function tests showed aspartate aminotransferase of 2516 IU/dL and alanine aminotransferase of 957 IU/dL. Immunoglobulin G antibody titer was 3831 mg/dL. Viral hepatitis panel was negative. Immunologic workup revealed positive ANA with a titer of 1/320 by immunofluorescence assay, anti-dsDNA (titer 1/160; reference ,1/10), anti-SSA, and positive and negative anti-Smith antibodies. F-actin antibody, which has been shown to have great sensitivity and specificity in autoimmune hepatitis, was also highly positive with a titer of 83 units (reference ,19 units). Anti-RNP antibodies were negative. Her serum compliment levels were slightly lower than the normal. Magnetic resonance imaging of the lower extremities showed findings consistent with myositis. Computed tomography of the abdomen with contrast showed findings suggestive of early cirrhosis. Patient underwent biopsy of the thigh muscles, which showed inflammatory myositis ( Figure 1 ). Liver biopsy was characteristic of autoimmune hepatitis ( Figure 2 ). Patient was treated with intravenous fluid, immunosuppressive therapy with azathioprine and prednisone, which was gradually tapered to a lower maintenance dose. She had significant improvement of her symptoms and was discharged to a rehabilitation facility. At follow-up, her myalgia and myopathy had resolved.
DISCUSSION
Statins are widely prescribed for the primary and secondary prevention of cardiovascular disease because of atherosclerosis, and it is estimated that over 25 million patients worldwide are taking these medication. 1 They are generally considered safe. However, recent data from long-term follow-up on patients who are on statins for long duration suggest that prolonged exposure to statins may trigger autoimmune reactions, such as systemic lupus erythematosus (SLE), subacute cutaneous lupus erythematosus, dermatomyositis, and polymyositis. 2 Reports on Medline data search since 1966 have shown only 28 reported cases of statininduced lupus-like syndrome. There were 2 cases of autoimmune hepatitis reported in patients with possible statin-induced SLE. 1 In a reported case, atorvastatin and ezetimibe combination was attributed to be the cause of autoimmune thyroid disorder and autoimmune hepatitis. 3 Drug-induced hepatitis is often associated with antibodies directed against hepatic drug-metabolizing enzymes. 4 Drug-induced autoimmune reactions are unrelated to the chemical structure of statins. Statins in general cause noninflammatory myopathy. However, there are data to support that statin may also cause inflammatory myopathy. 1 Muscle biopsy findings of our patient were consistent with inflammatory myositis (Figure 1 ). The skeletal muscle showed areas of mild perivascular lymphocytic infiltration and moderate coinciding myocyte regeneration and necrosis. Features such as extensive fiber atrophy, increased lipid deposition, or isolated necrosis or regeneration, suggestive of a statininduced injury, were not present. The liver biopsy showed features of autoimmune hepatitis, including portal and lobular inflammation with a considerable plasma cell population and severe disease activity with areas of confluent necrosis (Figure 2) .
The exact mechanism of statin-induced autoimmune reaction is unclear. Statins are potent proapoptotic agents that would enhance cellular apoptosis and release of nuclear antigen into the circulation. This may induce the production of pathogenic autoantibodies. 5 The role of statins in inducing an endoplasmic reticular stress response with associated upregulation of major histocompatibility complex-1 expression and antigen presentation by muscle fibers has also been reported. 6 Systemic immunosuppressive therapy has proven to be effective in many reported cases.
We report this case to highlight this association and educate the clinician to consider this in the differential when evaluating and treating a patient presenting with autoimmune disorders. Although our patient did not have the florid clinical findings of SLE, close monitoring for development of lupus-like syndrome is warranted in this case.
